Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P.J. Barnes (London, United Kingdom). New mechanisms and targets in COPD. International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD

Member's Comments

Hugo Farne - 22.09.2014 01:16
Would have been 5/5 if English slides were also available!

Related content which might interest you: New targets for drug development in asthma Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 New pathways, new targets  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 New aspects of COPD ethiopathogenesis Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 New drugs for severe asthma – what should we target and how? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 New therapeutic targets Source: Annual Congress 2007 - COPD – a disease of accelerated ageing? Year: 2007 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 New treatment approaches for IPF Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis Year: 2016 Translating mechanisms to new drugs for COPD exacerbations Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Genes, intervention and molecular mechanisms in COPD Source: Annual Congress 2007 - Physiological year in review Year: 2007 New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 New Drugs for COPD: the current status Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014